Envestnet Portfolio Solutions’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$342K Sell
2,094
-1,606
-43% -$247K ﹤0.01% 1053
2025
Q4
$644K Sell
3,700
-464
-11% -$84.7K ﹤0.01% 944
2025
Q3
$600K Sell
4,164
-1,027
-20% -$126K ﹤0.01% 960
2025
Q2
$522K Sell
5,191
-705
-12% -$53.9K ﹤0.01% 1080
2025
Q1
$450K Sell
5,896
-418
-7% -$32K ﹤0.01% 1094
2024
Q4
$436K Buy
6,314
+225
+4% +$16.2K ﹤0.01% 1305
2024
Q3
$444K Buy
6,089
+1,168
+24% +$86.2K ﹤0.01% 1265
2024
Q2
$330K Buy
+4,921
New +$191K ﹤0.01% 1332

Other funds holding INSM

Envestnet Portfolio Solutions's INSM Position: Q1 2026 in Review

Envestnet Portfolio Solutions reduced its Insmed (INSM) stake by 43% in Q1 2026, selling an estimated $247K and leaving 2,094 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #1053.

Envestnet Portfolio Solutions first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $644K in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Envestnet Portfolio Solutions held 2,094 shares of Insmed worth $342K as of Q1 2026.
  • Envestnet Portfolio Solutions sold 1,606 Insmed shares in Q1 2026, an estimated $247K.
  • Insmed made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q1 2026, its #1053 holding.
  • Envestnet Portfolio Solutions first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • Envestnet Portfolio Solutions's Insmed position peaked at $644K in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q1 2026, filed 29 Apr 2026.